ABSTRACT Early embryogenesis in
pressed in the dorsal blastopore lip of the embryonic gastrula where it functions in brain development (Chen et al., 2001 ). Second, the Cyp26 genes are important for RA metabolism (White et al., 1996) , with xCyp26A, B, and C implicated in Xenopus embryogenesis (Hollemann et al., 1998; de Roos et al., 1999; Kudoh et al., 2002) .
In a previous DNA microarray screen for novel genes that affect A-P neural patterning and that are regulated by canonical Wnt signaling (Tanibe et al., 2008; Michiue et al., 2007) , we identified chicken ovalbumin upstream promoter transcription factor (COUP-TF) as a candidate gene (reviewed in Pereira et al., 1995) . COUP-TF was first identified as a DNA-binding protein that interacts directly with the ovalbumin promoter (Pastorcic et al., 1986) . COUP-TF encodes a steroid/thyroid hormone receptor that contains a DNAbinding domain including two zinc finger domains and one ligandbinding domain (LBD) (Evans, 1988) . In Drosophila, COUP-TF is a causative gene of the seven-up mutation (Mlodzik et al., 1990) , while two homologues of COUP-TF, xCOUP-TF-A and xCOUP-TF-B, have been identified in Xenopus. In this study, it is shown that xCOUP-TF-B is similar with mammalian COUP-TFII, and that xCOUP-TFA is distinct with xCOUP-TFI (Qiu et al., 1994; van der Wees et al., 1996) . These genes are differentially expressed (van der Wees et al., 1996) . For example, both genes are expressed in anterior neuroectoderm, but only COUP-TF-A is expressed in somite (van der Wees et al., 1996) . The function of COUP-TF has been extensively studied, with some studies revealing an inhibitory role in RA signaling (Tran et al., 1992; Kliewer et al., 1992) , and Xenopus COUP-TF implicated as a potential regulator of RA signaling in neural development (Schuh and Kimelman, 1995) .
This study of xCOUP-TF function revealed important cooperative roles with xCyp26 in A-P neural patterning. xCOUP-TF-B is expressed in restricted sets of rhombencephalon at the neurula stage and affects the expression of several brain markers. The xCOUP-TF-B expression was dependent on Wnt signaling and enhanced anteriorization in cooperation with xCyp26. Moreover, xCOUP-TF was found to promote xCyp26 transcription. These data suggests that a novel mechanism of A-P neural patterning could exist via the regulation of RA signaling.
Results
Microinjection with xCOUP-TF-B mRNA caused head defects and misexpression of neural marker genes As described in previous studies, dorsal injection with xCOUP-TF-B mRNA disrupted anterior neural development (Schuh and Kimelman, 1995) . To confirm this effect, we injected xCOUP-TF-B mRNA into the animal region of 4-8-cell embryos. Injection of 100 pg of xCOUP-TF-B mRNA into the dorso-animal (DA) region caused obvious head defects characterized by small eyes and a slightly bent axis (Fig. 1 A,B) , while ventro-animal injections induced abnormalities in the abdominal region of tadpoles (Fig. 1C) . We also observed transverse sections of the DA-injected embryos. Sections dissected at the eye vesicle showed that xCOUP-TF-B caused shrinkage of the diencephalon and loss of eye vesicles (Fig. 1 D,F) , and sections cut across the otic vesicles revealed hindbrain enlargement (Fig. 1 E,G) .
In a previous study (Schuh and Kimelman, 1995) , overexpression of xCOUP-TF-B mRNA altered the spatial expression of several genes such as En2 (a mid-hind brain marker), Krox20 (a rhomben- , and Xtwist (a neural crest marker). To confirm these results, we performed whole-mount in situ hybridization. As described previously, xCOUP-TF-B mRNA injection disrupted En2 and Krox20 expression (Fig. 1H ). Indeed, a complete absence of Krox20 expression ( Fig. 1H ), while the pattern of En2 expression was slightly broadened and weakened ( Fig. 1H ). We also examined other neural markers. In xCOUP-TF-B injected embryo, xslug expression shifted posteriorly, suggesting anteriorization ( 
XCOUP-TF-B attenuated posteriorization by RA
Previous reports implicated an inhibitory role for xCOUP-TF in RA signaling, and RA treatment is known to induce posteriorization in Xenopus embryo. We therefore examined whether xCOUP-TF could inhibit such an effect. First, we injected xCOUP-TF-B mRNA into the DA region of 4-cell embryos, followed by treatment with RA solution at Stage 8. Without injection, treatment with 10 -7 M RA induced a slight head defect with small eye, while 10 -6 M RA treatment caused more severe defects ( Fig. 2 B,C) . In addition, the head shrinkage caused by treatment with RA was not rescued by the injection of xCOUP-TF-B mRNA ( Fig. 2 E,F) .
Next, we carried out RT-PCR analysis on these embryos. BF1 (telencephalon marker) and Xotx2 (forebrain marker) expressions were decreased with elevated RA concentration (Fig. 2G , lane 1-3). Conversely, xCOUP-TF-B-injected embryos showed suppression of the 10 -7 M RA-induced decrease in BF1 and Xotx2 expression (Fig. 2G , lane 2 and 5). On the other hand, xCOUP-TF-B could not recover BF1 and Xotx2 expression in embryo with 10 -6 M RA treatment (Fig. 2G , lane 3 and 6).
We then assessed Krox20 and En2 expression further by in situ hybridization. Embryos treated with 10 -7 M RA showed a posterior shift in Krox20 expression in rhombomere 5 on the injected side (Fig. 2H) , and this change was more apparent than in normal embryos without RA treatment (compare with Fig. 1H ). Similar to En2/Krox20, the xslug expression area (neural crest marker) was also posteriorly shifted (Fig. 2I) . These results suggest that xCOUP-TF-B attenuates posteriorization caused by RA.
Canonical Wnt signaling downregulated expression of xCOUP-TF-B
DNA microarray results suggested that xCOUP-TF-B expression is affected by canonical Wnt signaling. To confirm this, we carried out RT-PCR on b-catenin-injected embryos. b-catenin mRNA injection decreased the level of xCOUP-TF-B transcription, whereas 10 ng of b-catenin MO injection slightly promoted xCOUP-TF-B transcription, and 20 ng injection weakly suppressed xCOUP-TF-B expression (Fig. 3A) . Similar elevations were observed in xCyp26C and Xotx2 expression (Fig. 3A) . The b-catenin-injected embryos also showed inhibition of spatial expression of xCOUP-TF-B (Fig.  3B ). These data together suggests that xCOUP-TF-B is negatively regulated by canonical Wnt signaling.
Coinjection of xCOUP-TF-B with xCyp26C enhanced the anterior defect
We also previously reported that xCyp26C is important for precise anterior neural patterning (Tanibe et al., 2008) . Indeed, our microarray analysis identified both xCyp26C and xCOUP-TF-B as genes whose transcripts were more abundant in the anterior half of neurula than in the posterior half. Furthermore, it is known that both xCyp26C and xCOUP-TF-B negatively regulate RA signaling. We therefore hypothesize that xCOUP-TF-B is involved with xCyp26C function. To assess this possibility, we first compared the spatial expression of xCOUP-TF-B with that of xCyp26C. As previously described, xCyp26C was expressed in restricted subsets of rhombomere and cranial placode (Fig. 4 C, D: Tanibe et al., 2008) . xCOUP-TF showed a similar pattern of expression to that of xCyp26C in rhombencephalon (Fig. 4 A,C) , while both xCOUP-TF-B and xCyp26C expression was also seen in some sets of cranial placodal nerves, which were anterodorsal lateral line, anteroventral lateral line, and epibranchial IX (Fig. 4 A-D: Schlosser and Northcutt (2000); Baker and Bronner-Fraser (2001)). Although similar, there were some differences between the expression patterns of xCyp26C and xCOUP-TF-B. For example, these genes were differently expressed in each each placodal nerve (Fig. 4A-D) , while only xCOUP-TF-B expression was observed in eye, otic vesicles, and telencephalic regions (Fig. 4 A,C and Fig. 4 B and D) .
To further explore the expression of these genes, we carried out co-injection analyses using xCOUP-TF-B and xCyp26C. In this experiment, we also used xCyp26A, another xCyp26-family member. A low dose of xCOUP-TF-B injected into the DA region of embryos caused minimal head defect (Fig. 5B) . Similarly, injection of 250 pg of xCyp26A showed normal phenotype (Fig. 5C ). On the other hand, the co-injection of xCOUP-TF-B and xCyp26A induced a more marked head defect compared to that caused by xCOUP-TF-B alone (Fig. 5D ). Co-injection with xCyp26C also showed similar effects on head defect (Fig. 5 E,F) . More detailed examination confirmed that eye size was clearly reduced in the co-injected embryos (Fig. 5G) .
xCOUP-TF-B increased xCyp26A and xCyp26C transcription
The co-injection analysis suggests that xCOUP-TF-B could positively affect xCyp26A/C function. Previous results indicated a direct association between xCOUP-TF and RXR that negatively regulates RA signaling by competing with RAR (Kliewer et al., 1992) . We therefore hypothesized that xCOUP-TF-B regulates xCyp26A/C transcription. To test this, we examined whether xCOUP-TF-B modulates the level of xCyp26A/C expression. RT- PCR analysis revealed that xCOUP-TF-B overexpression increased the expressions of both xCyp26C and xCyp26A (Fig. 6A, 1st and 2nd column). Subsequent in situ hybridization of xCOUP-TF-Binjected embryos indicated little change in the expressions of xCyp26A (Fig. 6B) ; however, xCyp26C expression increased in xCOUP-TF-B -injected areas (Fig. 6C) . These results suggest that xCOUP-TF-B upregulates xCyp26C transcription.
Discussion
This study showed that xCOUP-TF acts cooperatively with xCyp26A/C in A-P neural patterning of early embryogenesis. XCOUP-TF-B injection increased the expression of several anterior neural genes, and suppressed RA-induced effects. Indeed, these results seemed to implicate an anteriorizing function for xCOUP-TF. Ectopic expression of xCOUP-TF-B caused eye defect and enlarged hindbrain formation. This result could reflect an anteriorization effects, but the inhibitory function of xCOUP-TF for RA signaling is dominant in hindbrain and the eye defect may reflect a separate function independent of RA signaling. In the previous report, 10 -6 M RA treatment suppressed COUP-TF-B expression in brain region (van der Wees et al., 1996) . However, this result may reflect loss of COUP-TF expression area by treatment with higher RA concentration.
In this study, xCOUP-TF-B synergistically enhanced the superficial phenotype caused by xCyp26A/C, although because xCyp26A/C is not a transcription factor, xCOUP-TF-B and xCyp26A/C are unlikely to function in parallel as cofactor(s). However, our findings suggest that xCOUP-TF-B and xCyp26A/C may work in the same regulation network as described in Fig. 6D . Indeed, we showed that xCOUP-TF-B enhanced xCyp26A/C transcription, suggesting that xCOUP-TF-B physically interacts with the upstream region of xCyp26A/C gene. RA response element (RARE) sequences can be found upstream of the xCyp26A transcribed region, but not in that of xCyp26C (Tanibe et al., unpublished) . To clarify our working hypothesis, further investigation is needed to identify the exact regulatory regions.
We also demonstrated the dependency on Wnt signaling in xCOUP-TF-B transcription. Supporting the microarray analysis, xCOUP-TF-B transcription was decreased by b-catenin-mRNA injection. Interestingly, the gene expressions of both xCyp26A/C and xCOUP-TF-B are increased by the modulation of canonical Wnt signaling, suggesting crosstalk between Wnt and RA signaling. In particular, the fact that RA signaling factors are regulated by Wnt signaling may reflect epistasis of Wnt for RA signaling.
Based on the results of this study, we have proposed a model as follows (Fig. 6D). (1) Wnt signaling negatively regulates expression of both Cyp26A/C and xCOUP-TF-B. (2) RA signaling positively regulates both xCyp26A/C and xCOUP-TF-B. (3) xCOUP-TF-B positively regulates xCyp26A/C expression. (4) Both xCOUP-TF-B and xCyp26C negatively regulate RA signaling. In context of head specification, canonical Wnt signaling is negative regulated, followed by promotion of both xCOUP-TF-B and xCyp26A/C. We also propose that transcriptional enhancement of xCyp26A/C by xCOUP-TF-B will help to maintain low RA levels, and that ectopic expression of both xCOUP-TF-B and xCyp26A/C by exposure to RA could also be important for recovering normal RA level and precise anterior specification. Further extensive biochemical analyses are needed to clarify the molecular mechanisms underlying our model.
Materials and Methods

DNA constructs
DNA fragments of the xCOUP-TF-B gene were amplified by RT-PCR, and then ligated into pBluescriptSK(+) to make the pXCOUP-TF-B/SK construct. For the injection construct (pXCOUP-TF-B/CS), we inserted an EcoRI-XhoI fragment of pXCOUP-TF/SK into pCS2(+).
Microinjection
Messenger RNAs for microinjection were synthesized using the mMessage mMachine SP6 kit (Ambion) and were cleaned up with an RNeasy RNA purification kit (QIAGEN). Transcribed mRNA was injected using a Picoinjector (Harvard Medical Instrument). Xenopus embryos were obtained by artificial fertilization and dejellied with 4.6% L-cysteine hydroxychloride. Injection was performed in 5% Ficoll-Steinberg's solution, and injected embryos were cultured in the same solution for 5 hours, and then in 10% Steinberg's solution until the appropriate developmental stage.
In situ hybridization
In situ hybridization was carried out as previously described (Tanibe et al., 2008) . In brief, embryos were bleached in hydrogen peroxide-methanol before fixation in MEMFA solution (formaldehyde-MOPS solution) and dehydration with ethanol. Rehydrated embryos were hybridized with DIGlabeled probe for 24 h at 60°C. Embryos were then incubated with 2000 x anti-DIG antibody (Roche) for 12 h, washed 5 times, and then visualized by reaction in NBT/BCIP solution.
RT-PCR
We used the SuperscriptII reverse transcriptase (Invitrogen) for cDNA synthesis. Primers for PCR were as follows: xCOUP-TF-B 5'-CGAATCTTCCAAGAGCAG GTC -3' and 5'-TTA TTG TAT GGA CAT ATA GGG CC-3'; xCyp26c 5'-ACGAGG GGAAACTGGGCAAATTCAAC-3' and 5'-TCAGGCAAGTGACCCATTTCTTGC TGC-3'; xCyp26a 5'-CTTGCGGAGGTGGAGTGA GGT G-3' and 5'-GCTTAAATA GAGCTGGAGAAGGG-3'; Xotx2 5'-GGATGGATTTGTTACATCCGTC-3' and 5'-CACTCTCCGAGCTCACTTCCC-3'; XAG-1 5'-CATATGTGGTCCCAG TTATTTCCC-3' and 5'-CTCTTAGCGGTTTGAAACCGA-3'; BF1 5'-CATCGTTCAGTATCAACAGCC-3' and 5'-GACTCTCTGTCTTCACTTCCAGG-3'; En2 5'-ATGAGCAGAATAACAGGGAAGTGGA-3' and 5'-CCTCGGGGACATTGACTCGGTGGTG-3'; xSlug 5'-GGATACCCTTCATCTTTAGGTCG-3' and 5'-CATAAGCTGCACTGGAACTTCTC-3'; ODC 5'-GCCATTGTGAAGACT CTCTCCATTC-3' and 5'-TTCGGGTGATTCCTTGCCAC-3'. For DNA amplification, we used PTC-200 thermal cycler (MJ Research / BioRad). In any cases, we performed 28 cycles of (95°C, 15sec. -56°C, 15 sec.-72°C, 30sec.) chain reaction. Amplified DNA was detected by EtBr staining after agarose gel electrophoresis.
